Abstract
Introduction: Individualized maximum repeatable dose (iMRD) is the maximum dose at which a drug can be repeated in an individual to maintain the toxicity grade at 1 or lower. In this phase I study, the starting dose to estimate the iMRD in weekly paclitaxel treatment for recurrent and/or head and neck cancer patients was determined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.